Form 4: ANI Pharmaceuticals SVP, Generics, Ori Gutwerg, Sells Shares

Ori Gutwerg, SVP, Generics at ANI Pharmaceuticals, sold 2,985 shares of common stock on June 5, 2024, at a price of $67 per share.

Summary

• On June 5, 2024, Ori Gutwerg, the SVP, Generics of ANI Pharmaceuticals, sold 2,985 shares of the company's common stock.
• The sale was executed at a price of $67 per share.
• Following the transaction, Gutwerg directly owns 77,227 shares of ANI Pharmaceuticals.

Sentiment

Score: 5

Explanation: Neutral sentiment as it's a standard disclosure of a stock sale by an executive. The sale itself doesn't necessarily indicate a positive or negative outlook.

Industry Context

Form 4 filings are standard disclosures required by the SEC when corporate insiders buy or sell their company's stock. It provides transparency into the transactions of individuals with access to non-public information.

Stakeholder Impact

• The sale of shares by a company executive could be perceived negatively by some shareholders, although it is a common occurrence.

Key Dates